Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Fusion Pharmaceuticals Inc. (FUSN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/09/2023 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 500,000 options to buy
@ $3.75, valued at
$1.9M
|
|
| 01/09/2023 |
4
| Rawat Mohit (President and CBO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.75, valued at
$1.1M
|
|
| 01/09/2023 |
4
| Leamon Christopher P (Chief Scientific Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 250,000 options to buy
@ $3.75, valued at
$937.5k
|
|
| 01/09/2023 |
4
| Crowley John J (CFO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 250,000 options to buy
@ $3.75, valued at
$937.5k
|
|
| 01/09/2023 |
4
| Burak Eric (Chief Technology Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 250,000 options to buy
@ $3.75, valued at
$937.5k
|
|
| 11/14/2022 |
4
| Khuong Chau Quang (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 42,093 shares
@ $2.38, valued at
$100.2k
|
|
| 11/07/2022 |
4
| Bobilev Dmitri (Chief Medical Officer) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 550,000 options to buy
@ $1.98, valued at
$1.1M
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Lee Philina (Director) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Granted 17,000 options to buy
@ $3.6, valued at
$61.2k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 2,036 shares
@ $6.03, valued at
$12.3k
Sold 2,147 shares
@ $6.07, valued at
$13k
Sold 4,511 shares
@ $6.03, valued at
$27.2k
|
|
| 04/22/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 367 shares
@ $6.02, valued at
$2.2k
Sold 922 shares
@ $6.01, valued at
$5.5k
|
|
| 04/13/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 2,600 shares
@ $7.37, valued at
$19.2k
Sold 18,255 shares
@ $7.1, valued at
$129.6k
Sold 11,994 shares
@ $6.41, valued at
$76.9k
|
|
| 04/08/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 100 shares
@ $7.58, valued at
$758
Sold 1,255 shares
@ $7.56, valued at
$9.5k
Sold 826 shares
@ $7.52, valued at
$6.2k
|
|
| 04/05/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 1,000 shares
@ $7.75, valued at
$7.8k
Sold 700 shares
@ $7.81, valued at
$5.5k
Sold 2,100 shares
@ $7.67, valued at
$16.1k
|
|
| 04/01/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 300 shares
@ $7.52, valued at
$2.3k
|
|
| 03/29/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 500 shares
@ $7.42, valued at
$3.7k
Sold 9,600 shares
@ $7.55, valued at
$72.5k
Sold 200 shares
@ $7.52, valued at
$1.5k
|
|
| 03/24/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 4,000 shares
@ $7.53, valued at
$30.1k
Sold 100 shares
@ $7.5, valued at
$750
Sold 700 shares
@ $7.46, valued at
$5.2k
|
|
| 03/21/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 900 shares
@ $7.51, valued at
$6.8k
Sold 1,204 shares
@ $7.61, valued at
$9.2k
Sold 1,500 shares
@ $7.47, valued at
$11.2k
|
|
| 03/16/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 1,300 shares
@ $6.96, valued at
$9k
Sold 100 shares
@ $7.12, valued at
$712
Sold 100 shares
@ $6.99, valued at
$699 |
|
| 03/14/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 822 shares
@ $6.94, valued at
$5.7k
Sold 1,900 shares
@ $7.06, valued at
$13.4k
Sold 100 shares
@ $7.13, valued at
$713 |
|
| 03/08/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 8,400 shares
@ $7.32, valued at
$61.5k
Sold 3,100 shares
@ $6.99, valued at
$21.7k
Sold 3,004 shares
@ $6.92, valued at
$20.8k
|
|
| 03/03/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 847 shares
@ $7.37, valued at
$6.2k
Sold 26,546 shares
@ $7.44, valued at
$197.5k
Sold 200 shares
@ $7.28, valued at
$1.5k
|
|
| 02/28/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 2,500 shares
@ $7.41, valued at
$18.5k
Sold 8,152 shares
@ $7.57, valued at
$61.7k
Sold 3,100 shares
@ $7.4, valued at
$22.9k
|
|
| 02/23/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 4,898 shares
@ $7.88, valued at
$38.6k
Sold 4,100 shares
@ $7.85, valued at
$32.2k
Sold 29,299 shares
@ $7.77, valued at
$227.7k
|
|
| 02/17/2022 |
4
| Valliant John (CEO) has filed a Form 4 on Fusion Pharmaceuticals Inc.|
Txns:
| Sold 12,600 shares
@ $8.33, valued at
$105k
Sold 33,202 shares
@ $7.99, valued at
$265.3k
Sold 1,700 shares
@ $7.98, valued at
$13.6k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|